(AFX UK Focus) 2007-10-22 15:36 GMT: Genzyme's Renvela gets FDA approval for dialysis patients (Interactive Investor)
BOSTON (Thomson Financial) - Genzyme Corp. said Monday the Food and Drug Administration has approved the company's Renvela drug for the control of serum phosphorus in patients with chronic kidney disease on dialysis.

FDA Approves Genzyme's Renvela(TM) for Dialysis Patients (The San Francisco Examiner)
Oct 22, 2007 3:02 AM (8 hrs ago) From Genzyme Corp., Distributed by Press Release